The role of antimicrobials in Crohn’s disease

References

• Prantera C, Scribano ML. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how. Curr. Opin. Gastroenterol. 25(4), 329–333 (2009).
   PubMed Web of Science ®Google Scholar
• Abraham C, Cho JH. Inflammatory bowel disease. N. Engl. J. Med. 361(21), 2066–2078 (2009).
   PubMed Web of Science ®Google Scholar
• Macfarlane S, Steed H, Macfarlane GT. Intestinal bacteria and inflammatory bowel disease. Crit. Rev. Clin. Lab. Sci. 46(1), 25–54 (2009).
   PubMed Web of Science ®Google Scholar
• BestWR, BecktelJM, SingletonJW, KernF Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70(3), 439–444 (1976).
   PubMed Web of Science ®Google Scholar
• Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn’s disease in adults. Am. J. Gastroenterol. 104(2), 465–483; quiz 464, 484 (2009).
   PubMed Web of Science ®Google Scholar
• Blichfeldt P, Blomhoff JP, Myhre E, Gjone E. Metronidazole in Crohn’s disease. A double blind cross-over clinical trial. Scand. J. Gastroenterol. 13(1), 123–127 (1978).
   PubMed Web of Science ®Google Scholar
• Sutherland L, Singleton J, Sessions J et al. Double blind, placebo controlled trial of metronidazole in Crohn’s disease. Gut 32(9), 1071–1075 (1991).
   PubMed Web of Science ®Google Scholar
• Rosén A, Ursing B, Alm T et al. A comparative study of metronidazole and sulfasalazine for active Crohn’s disease: the cooperative Crohn’s disease study in Sweden. I. Design and methodologic considerations. Gastroenterology 83(3), 541–549 (1982).
   PubMed Web of Science ®Google Scholar
• Ursing B, Alm T, Bárány F et al. A comparative study of metronidazole and sulfasalazine for active Crohn’s disease: the cooperative Crohn’s disease study in Sweden. II. Result. Gastroenterology 83(3), 550–562 (1982).
   PubMed Web of Science ®Google Scholar
• Ambrose NS, Allan RN, Keighley MR et al. Antibiotic therapy for treatment in relapse of intestinal Crohn’s disease. A prospective randomized study. Dis. Colon Rectum 28(2), 81–85 (1985).
   PubMed Web of Science ®Google Scholar
• Arnold GL, Beaves MR, Pryjdun VO, Mook WJ. Preliminary study of ciprofloxacin in active Crohn’s disease. Inflamm. Bowel Dis. 8(1), 10–15 (2002).
   PubMed Web of Science ®Google Scholar
• West RL, Van Der Woude CJ, Hansen BE et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn’s disease with infliximab: a double-blind placebo-controlled study. Aliment. Pharmacol. Ther. 20(11–12), 1329–1336 (2004).
   PubMed Web of Science ®Google Scholar
• Colombel JF, Lémann M, Cassagnou M et al. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn’s disease. Groupe d’Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Am. J. Gastroenterol. 94(3), 674–678 (1999).
   PubMed Web of Science ®Google Scholar
• Thia KT, Mahadevan U, Feagan BG et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn’s disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm. Bowel Dis. 15(1), 17–24 (2009).
   PubMed Web of Science ®Google Scholar
• Steinhart AH, Feagan BG, Wong CJ et al. Combined budesonide and antibiotic therapy for active Crohn’s disease: a randomized controlled trial. Gastroenterology 123(1), 33–40 (2002).
   PubMed Web of Science ®Google Scholar
• Prantera C, Zannoni F, Scribano ML et al. An antibiotic regimen for the treatment of active Crohn’s disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am. J. Gastroenterol. 91(2), 328–332 (1996).
   PubMed Web of Science ®Google Scholar
• Leiper K, Martin K, Ellis A, Watson AJ, Morris AI, Rhodes JM. Clinical trial: randomized study of clarithromycin versus placebo in active Crohn’s disease. Aliment. Pharmacol. Ther. 27(12), 1233–1239 (2008).
   PubMed Web of Science ®Google Scholar
• Prantera C, Lochs H, Campieri M et al. Antibiotic treatment of Crohn’s disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment. Pharmacol. Ther. 23(8), 1117–1125 (2006).
   PubMed Web of Science ®Google Scholar
• Prantera C, Lochs H, Grimaldi M, Danese S, Scribano ML, Gionchetti P; Retic Study Group (Rifaximin-Eir Treatment in Crohn’s Disease). Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn’s disease. Gastroenterology 142(3), 473–481.e4 (2012).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology 108(6), 1617–1621 (1995).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Van Assche G, Vermeire S et al. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 128(4), 856–861 (2005).
   PubMed Web of Science ®Google Scholar
• Khan KJ, Ullman TA, Ford AC et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am. J. Gastroenterol. 106(4), 661–673 (2011).
   PubMed Web of Science ®Google Scholar
• Doherty GA, Bennett GC, Cheifetz AS, Moss AC. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn’s disease. Aliment. Pharmacol. Ther. 31(8), 802–809 (2010).
   PubMed Web of Science ®Google Scholar
• Bernstein LH, Frank MS, Brandt LJ, Boley SJ. Healing of perineal Crohn’s disease with metronidazole. Gastroenterology 79(2), 357–365 (1980).
   PubMed Web of Science ®Google Scholar
• Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn’s disease: a follow-up study. Gastroenterology 83(2), 383–387 (1982).
   PubMed Web of Science ®Google Scholar
• Jakobovits J, Schuster MM. Metronidazole therapy for Crohn’s disease and associated fistulae. Am. J. Gastroenterol. 79(7), 533–540 (1984).
   PubMed Web of Science ®Google Scholar